MedPath

Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine

Phase 4
Completed
Conditions
Male Infertility
Interventions
Registration Number
NCT03802864
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

The study is a drug trial comparing the post-operative pain control provided by liposomal bupivacaine (a local anesthetic) against standard bupivacaine (a different formulation of the local anesthetic) for men undergoing testicular sperm extraction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
50
Inclusion Criteria
  • Men scheduled for surgical sperm retrieval for infertility
  • Men 18 years and older who can provide informed consent
  • No documented allergy to bupivacaine or celecoxib
Exclusion Criteria
  • Prior history of substance abuse
  • Any narcotic use within the last 3 months
  • Concomitant use of aspirin
  • Any of the following comorbidities: renal failure, heart disease, peptic ulcer disease, cerebrovascular disease, significant liver disease, untreated depression, chronic pain disorder, or bleeding diatheses
  • Medical history or concurrent illness that the investigator considers sufficiently serious to interfere with the conduct, completion, or results of this trial, or constitutes an unacceptable risk to the subject

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard BupivacaineStandard BupivacaineParticipants in this arm will have a single injection of standard bupivacaine (100mg bupivacaine hydrochloride) at the conclusion of their surgical sperm retrieval procedure.
Liposomal BupivacaineLiposomal BupivacaineParticipants in this arm will have a single injection of liposomal bupivacaine admixed with standard bupivacaine (266mg liposomal bupivacaine mixed with 50mg bupivacaine hydrochloride) at the conclusion of their surgical sperm retrieval procedure.
Primary Outcome Measures
NameTimeMethod
Pain Scores 48 Hours After SurgeryFirst 48 hours after surgery

Every 8 hours in the first 48 hours post-surgery, subjects were prompted to report their pain score on the 11-point numerical pain rating scale, NRS-11 (Numerical Rating Scale, 11 points). 0 indicates no pain and 10 indicates worst possible pain.

Each subject's pain scores were then plotted against time, and the area under the curve was then computed. The minimum composite score would be 0 (no pain ever reported), and the maximum composite score would be 480 (maximum pain (score of 10) reported each time across 48 hours).

Secondary Outcome Measures
NameTimeMethod
Pain Scores 7 Days After SurgeryFirst 7 days after surgery

Every 12 hours in the first 7 days post-surgery, subjects were prompted to report their pain score on the 11-point numerical pain rating scale, NRS-11 (Numerical Rating Scale, 11 points). 0 indicates no pain and 10 indicates worst possible pain.

Each subject's pain scores were then plotted against time, and the area under the curve was then computed. The minimum composite score would be 0 (no pain ever reported), and the maximum composite score would be 1680 (maximum pain (score of 10) reported each time across 168 hours).

Pain Scores 60 Hours After SurgeryFirst 60 hours after surgery

Every 12 hours in the first 60 hours post-surgery, subjects were prompted to report their pain score on the 11-point numerical pain rating scale, NRS-11 (Numerical Rating Scale, 11 points). 0 indicates no pain and 10 indicates worst possible pain.

Each subject's pain scores were then plotted against time, and the area under the curve was then computed. The minimum composite score would be 0 (no pain ever reported), and the maximum composite score would be 600 (maximum pain (score of 10) reported each time across 60 hours).

Narcotic RequirementFirst 7 days after surgery

Total number of narcotic tablets required between the intervention and control arms during post-operative day 1 through 7.

Time to Narcotic RescueFirst 7 days after surgery

Time (in hours) to first rescue narcotic utilization between the two arms.

Percentage of Patients Not Requiring Any Narcotics7th day after surgery

The percentage of patients remaining opiate free by post-operative day 7.

Pain Control Satisfaction7th day after surgery

Overall satisfaction of pain control regimen self reported on post-operative day 7. The prompt required a yes/no answer. The percent of participants answering "yes" will be compared between the two arms.

Trial Locations

Locations (1)

Weill Cornell Medicine Department of Urology

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath